Share of Cost, Advanced Treatment Technologies For Prostate Cancer Among Men With Low Risk Disease
Sunday, Feb. 9th 2014 8:00 AM
Use of advanced treatment technologies for prostate cancer, such as intensitymodulated radiotherapy and robotic prostatectomy, has increased among men with lowrisk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments, according to a study in the June 26 issue of JAMA. “Prostate cancer is a common and expensive disease in the United States. In part because of the untoward morbidity of traditional radiation and surgical therapies, advances in the treatment of localized disease have evolved over the last decade.
Related posts:
- Share of Cost, Prostate Cancer And Radiation Therapies, The Need For Additional Treatments In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton therapy […]...
- Therapies For Advanced Cancers Pose A Special Challenge For Health Technology Assessment Organizations In Many Countries Therapies For Advanced Cancers Pose A Special Challenge For Health Technology Assessment Organizations In Many Countries ...
- Share of Cost, For Acid Reflux Disease Patients, Esophageal Cancer Risk Lower Than Expected Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Modern Treatments For GERD Effective At Achieving Long-Term Remission For Most Patients In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA....
- Effects of Stopping Alcohol Consumption, Subsequent Risk of Esophageal Cancer Effects of Stopping Alcohol Consumption, Subsequent Risk of Esophageal Cancer...
- Share of Cost, Huge Cancer Knowledge Resource Made Public Share of Cost, Huge Cancer Knowledge Resource Made Public...
- Share of Cost, Deterioration in a Husband’s Health Likely When Wife Suffers Breast Cancer Share of Cost, Deterioration in a Husband's Health Likely When Wife Suffers Breast Cancer...
- Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe ...
- Esophageal Cancer May Be Caused By Migration Of Cancer-Causing Stomach Cells Esophageal Cancer May Be Caused By Migration Of Cancer-Causing Stomach Cells...
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in […]...
- Share of Cost, Cancer Pain Frequently Undertreated, Especially Among Minorities Share of Cost, Cancer Pain Frequently Under-treated, Especially Among Minorities...
- Transgenerational Genetic Effects – A Newly Discovered Mode Of Inheritance The study of epigenetics has undoubtedly emerged as one of the hottest fields of research over the past decade. Interest in epigenetics has arisen as researchers endeavor to reveal the underlying causes of phenotypic variation and common diseases despite technological advances allowing for the characterisation of genetic variants and their heritability…...
- Share of Cost, U.S. Autism Rates Reach New High According to CDC Report Share of Cost, U.S. Autism Rates Reach New High According to CDC Report...
- Share of Cost, Chronic Gastroesophageal Reflux Disease – Medication And Surgery Equally Effective Laparoscopic antireflux surgery or taking proton pump inhibitor esomeprazole for chronic GERD (chronic gastroesophageal reflux disease) were both found to result in similar rates of disease remission of five years, researchers from Nantes University, France, reported in JAMA (Journal of the American Medical Association)....
Posted on Sunday, Feb. 9th 2014 8:00 AM | by Share of Cost | in Share of Cost | No Comments »